CSIMarket
 
Biocorrx Inc   (BICX)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $0.3400 $0.00 0.000%
Day's High: $0.358 Week Perf: 0.00
Day's Low: $ 0.34 30 Day Perf: -3.13 %
Volume (M): 0 52 Wk High: $ 1.45
Volume (M$): $ 0 52 Wk Avg: $0.38
Open: $0.36 52 Wk Low: $0.20



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 15
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Biocorrx Inc
Biocorrx Inc is a healthcare company that specializes in developing and providing innovative solutions for the treatment of substance use disorders. The company's main focus is on developing medication-assisted treatment programs that combine pharmaceuticals with counseling and support to help individuals overcome addiction. Biocorrx's flagship product is the BICX101, an implantable, biodegradable pellet that delivers medication for the treatment of alcohol and opioid dependence. The company also provides support services to healthcare professionals and patients, including physician training, counseling, and aftercare. Biocorrx Inc aims to improve patient outcomes and revolutionize the way substance use disorders are treated.


   Company Address: 2390 East Orangewood Avenue Anaheim 92806 CA
   Company Phone Number: 462-4880   Stock Exchange / Ticker: BICX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CMPS        5.47% 
MNMD   -1.67%    
• View Complete Report
   



Biocorrx Inc

Biocorrx Inc Faces Severe Decline in Financial Performance During Fiscal Quarter Ending March 31, 2024

Biocorrx Inc (BICX) recently disclosed its disastrous fiscal three months ending March 31, 2024, which showed a significant decline in revenue to $0.00 million and an extended net loss per share of $-0.14, compared to the same period a year ago. This news comes as a shock to investors, especially considering the positive top-line gain posted by the Healthcare Facilities industry as a whole in the first quarter of 2024.
In comparison to the previous financial reporting period, Biocorrx Inc has seen a drastic decrease in its financial performance. The company's net loss per share has widened from $-0.10 to $-0.14, while revenue has plummeted from $0.02 million to $0.00 million. Additionally, the company reported a net shortfall of $-0.001 million, compared to a deficit of $-0.001 million in the same period last year.

Biocorrx Inc

Biocorrx Inc Battles Through Tough Times in the Healthcare Facilities Industry

Biocorrx Inc (BICX) recently declared its financial results for the three months ending December 31, 2023, and unfortunately, the numbers were disappointing. With a sharp decline in revenue by -77.15% to $0.02 million and a substantial increase in the shortfall per share to $-0.10, compared to the previous year's figures, it seemed like a disastrous period for the company.
However, when we consider the overall growth in the Healthcare Facilities industry during the fourth quarter of 2023, Biocorrx Inc's performance appears to be an anomaly. The industry witnessed a 12.93% growth in topline revenues from the corresponding period a year ago. This contrasting growth highlights the challenges and unique circumstances faced by Biocorrx Inc during this timeframe.

Biocorrx Inc

Biocorrx Inc faces a make-or-break period as it navigates the pivotal July to September 2023 quarter

Biocorrx Inc, a healthcare facilities company, has recently released its financial report for the fiscal period ending September 30, 2023. The report reveals several interesting facts about the company's performance during that time.
One of the key highlights is the improvement in Biocorrx Inc's earnings per share (EPS). In comparison to the previous year, where the company had a loss per share of $-0.13, the fiscal period ending September 30, 2023, showed a reduced loss per share of $-0.10. Additionally, EPS improved from $-0.11 per share in the previous reporting season, indicating positive growth.

Biocorrx Inc

Biocorrx Inc Delivers Impressive Financial Results with Strong Top-line Surge in Q2 2023

Biocorrx Inc Shows Improvement in Financial Performance
Biocorrx Inc, a healthcare facilities company, has reported a positive financial second quarter for 2023. The company decreased its loss per share from $-0.19 to $-0.11 compared to the previous year, showing an improvement in performance. Additionally, earnings per share also improved from $-0.13 to $-0.11 in the prior reporting season.
In terms of revenue, Biocorrx Inc experienced a rapid increase of 22.703% to $0.02 million, compared to the same reporting season a year prior. However, there was a sequential decrease in revenue by -51.449% from $0.04 million. Despite this decline, Biocorrx Inc has outperformed its sector peers in terms of revenue advancement, as the Healthcare Facilities sector showed a modest 8.08% increase during the same period.

Biocorrx Inc

Biocorrx Inc Outperforms Projections, Recorded a Minimal Deficit of $-0.13 per Share in Q1 2023!

19 as it is not mentioned in the financial results.

Biocorrx Inc, a healthcare facilities company, has reported improving financial results for the first quarter of 2023, demonstrating that they are on track to generate positive cash flow for the company. The most significant improvement in their financial metrics has been in the area of outstanding accounts receivable, which shows that they are effectively managing their liquidity and credit risk.







Biocorrx Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com